Kazunori Nagasaka

No ORCID on file · 7 papers in corpus · active 2007-2025

Study types

  • article 6
  • case-report 1

Condition tags

  • endometriosis 3
  • adenomyosis 2
  • chronic_pelvic_pain 1
  • infertility 1
case-report 2025
BMC women's health ·doi:10.1186/s12905-025-03681-8

BACKGROUND: Adenomyosis, characterized by endometrial tissue within the uterine muscle, often presents with severe pelvic pain and menorrhagia. This case series demonstrates the efficacy of sequential therapy involving relugolix followed by…

article 2024
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15993

AIM: As a treatment for tubal infertility, falloposcopic tuboplasty (FT) is one of the options for patients who wish to conceive naturally. Based on the results of FT, we propose an appropriate time of transitioning to assisted reproductive…

article 2021
BMC women's health ·doi:10.1186/s12905-021-01442-x

Abstract Background Recently, relugolix, an oral gonadotropin-releasing hormone receptor antagonist, has been considered an effective therapy for leiomyoma based on a phase 3 study in Japanese women. Leiomyoma combined with severe adenomyos…

article 2021
·doi:10.1016/j.heliyon.2021.e08696

Ulipristal acetate (UPA), a selective progesterone receptor modulator, is used for the treatment of uterine fibroids and selectively inhibits the proliferation and inflammation of leiomyoma cells. As few studies have focused on the molecula…

article 2021
·doi:10.2139/ssrn.3884693
article 2017
article 2007